Zaffre Investments

Managing Director Michele Courton Brown leads the investment function, supported by Director Jazmine Coleman and Senior Manager Flora Yu. The firm's website lists these three as the public-facing investment team. Brown's background is in health care finance, and the firm describes its collective professional experience at over 200 years across health care, finance, and investment.

Zaffre Investments is not a family office. It functions as the strategic investment entity tied to a Blue Cross Blue Shield health plan, making it a corporate venture arm in structure and mandate. The distinction matters for allocators: Zaffre invests for strategic alignment and operational integration rather than purely for financial return, and it does not manage outside limited partner capital in the manner of a commingled fund.

Zaffre runs a proprietary Health Equity Business Accelerator launched in 2021 that funds and mentors equity-focused health care startups, pairing financial backing with strategic guidance. Beyond the accelerator, the firm sources innovations it can pilot directly inside the health plan's operations, targeting five to seven new pilot integrations per year. This embedded distribution model gives portfolio companies a fast track to enterprise adoption, compressing the typical health-plan sales cycle.

Zaffre's published portfolio and mandate reveal a deliberate exclusion of non-health-care sectors; the firm's investment strategy and website content focus entirely on care delivery, access, affordability, and equity within the health care ecosystem. There is no indication of investments in fintech, enterprise SaaS, or industrial tech outside of health care applications. Deals that cannot integrate operationally into a regulated insurance value chain — claims data, provider networks, member engagement — appear outside the mandate.

The firm states it participates in investment through multiple avenues, specifically listing direct investments and collaborative partnerships. There is no mention of committing to third-party venture funds as a limited partner. The operating model emphasizes hands-on pilot integration, which is incompatible with passive fund-of-funds positions, suggesting an exclusively direct and co-investment posture.

Zaffre Investments is the strategic venture entity for a Blue Cross Blue Shield health plan, leveraging the payor's infrastructure to deploy and scale portfolio technologies. The firm uses the plan's membership base — cited as '3M+ lives' on Zaffre's website — as a pilot environment for startups. This relationship makes Zaffre's capital 'strategic' rather than purely financial, since every investment must map to the parent plan's operational needs.

Zaffre covers the full spectrum from seed and start-up stage through expansion and late-stage growth, categorized as General Venture. The firm's own description specifies 'funding for innovators across the growth trajectory,' and Altss records confirm active deployment across early-stage and late-stage venture. Investment size ranges are not publicly disclosed.